Strata Critical Medical, Inc. (SRTA)
NASDAQ: SRTA · Real-Time Price · USD
5.30
-0.06 (-1.12%)
At close: Jun 26, 2026, 4:00 PM EDT
5.22
-0.08 (-1.51%)
After-hours: Jun 26, 2026, 6:34 PM EDT

Strata Critical Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
46.9941.35-27.31-56.08-27.26-36.92
Depreciation & Amortization
9.558.195.967.115.731.17
Stock-Based Compensation
18.6517.8319.8912.58.2811.28
Other Adjustments
-3.58-107.21.9410.85-23.865.4
Change in Receivables
-11.37-12.03-1-10.25-5.35-1.74
Changes in Accounts Payable
2.52.38-8.349.059.92.52
Changes in Unearned Revenue
0.391.68-0.120.120.741.56
Changes in Other Operating Activities
-2.82-1.116.45-5.65-5.31-4.9
Operating Cash Flow
-44.78-48.91-2.52-32.35-37.13-21.63
Capital Expenditures
-2.3-9.6-30.86--0.73-0.49
Sale of Property, Plant & Equipment
0.06--0.14--
Purchases of Intangible Assets
-1.19-1.42-2.12-0.04--12.36
Purchases of Investments
-62.06-146.26-143.26-265.97-228.02-308.77
Proceeds from Sale of Investments
148.95296.36177.45285.07356.3828.51
Payments for Business Acquisitions
--66.54-2.23--48.1-23.07
Proceeds from Business Divestments
--2.81----
Other Investing Activities
----2.11-0.19-
Investing Cash Flow
74.0769.75-1.0217.0979.34-316.17
Long-Term Debt Repaid
------1.17
Net Long-Term Debt Issued (Repaid)
------1.17
Issuance of Common Stock
0.190.190.170.070.09335.04
Repurchase of Common Stock
-5.38-9.11-5.93-0.15-1.17-3.17
Net Common Stock Issued (Repurchased)
-5.2-8.91-5.76-0.08-1.08331.87
Other Financing Activities
-0.33-----
Financing Cash Flow
-5.53-8.91-5.76-0.08-1.08330.7
Effect of Exchange Rate Changes on Cash and Cash Equivalents
-0.47-0.34-0.08-0.070.07-0.01
Net Cash Flow
23.311.59-9.37-15.441.2-7.11
Free Cash Flow
-47.08-58.51-33.38-32.35-37.86-22.12
FCF Margin
-18.52%-29.68%-22.74%-14.37%-25.91%-32.93%
Free Cash Flow Per Share
-0.56-0.71-0.43-0.44-0.53-0.28
Levered Free Cash Flow
-9.0742.89-54.22-45.45-16.94-38.22
Unlevered Free Cash Flow
2.35-20.81-49.44-55.75-41.73-29.42
SEC Filings: 10-K · 10-Q